🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 83% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

3 Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
83% Evidence Coverage

Supplement Facts — Evidence Check

Bacopa monnieri
750 mg
200 mg
📊 Market median: 200.0mg (358 products) 📚 9 studies (Tier A: 0, B: 2)
This product: 200mg
200 mg
📊 Market median: 500.0mg (180 products) 📚 5 studies (Tier A: 0, B: 1)
This product: 200mg
180 mg
📊 Market median: 120.0mg (440 products) 📚 187 studies (Tier A: 1, B: 71)
This product: 180mg
100 mg
📊 Market median: 180.0mg (239 products) 📚 43 studies (Tier A: 1, B: 19)
This product: 100mg UL 400mg
1 mg (40000% DV)
📊 416.7× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 1mg

Other Ingredients

Acacia Gum

Label Claims — Verification

All Other
All Other (99% of products) Structure/Function (80% of products) Nutrient (4% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: Adults. Take 3 capsules a day.

⚠️ Warnings & Precautions

Precautions: Do not exceed the recommended daily dose. This product is a nutritional supplement and should not be used to replace a varied, balanced diet or healthy lifestyle.

Keep out of young children's reach.

As with all nutritional supplements, consult a health professional before taking if you are pregnant, breastfeeding or suffer from a health problem.

Additional Information

Store away from light, heat and humidity.

Product Details

UPC / SKU 5 453003 827603
DSLD Entry Date 2025-06-25
Product Type Other Combinations
Form Capsule
Brand SuperSmart
DSLD ID 332496
Data Updated 2026-04-11

Research Evidence

183 Research Sources
55 Avg Quality Score
86 Systematic Review
78 Meta Analysis
7 Other
4 Clinical Trial
2 Rct
2 Narrative Review
2 Regulatory Source
1 Openfda Safety
A Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2026
B Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2009
B Ginkgo biloba for tinnitus
Meta Analysis The Cochrane database of systematic reviews 2013
B Ginkgo biloba for tinnitus
Systematic Review The Cochrane database of systematic reviews 2022
B Ginkgo biloba for prevention of dementia: a randomized controlled trial
Rct JAMA 2008
B Effectiveness and safety of ginkgo biloba preparations in the treatment of Alzheimer's disease: A systematic review and meta-analysis
Systematic Review Frontiers in aging neuroscience 2023
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2013
B The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
Systematic Review Frontiers in aging neuroscience 2020
B Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2026
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2009
View all evidence for Ginkgo →

Compare Similar Products

View all Ginkgo products →